# Databricks notebook source
"""
Supply Chain Pharma Workshop -- Synthetic Supply Chain PDF Corpus for Knowledge Assistant RAG

Generates five extensive GMP/GDP-aligned PDF documents under Unity Catalog volume
``/Volumes/<catalog>/<schema>/documents``.

Requires network access for ``pip install`` on first run.
"""

import subprocess

subprocess.check_call(["pip", "install", "fpdf2"])

from fpdf import FPDF
import os
from datetime import date
from typing import List, Sequence, Tuple

# --- Configuration ---
dbutils.widgets.text("catalog", "pharma_workshop", "Catalog Name")
CATALOG = dbutils.widgets.get("catalog").strip()
assert CATALOG, "ERROR: Please provide a catalog name in the widget above before running."
SCHEMA = "wsp_supply_chain"
VOLUME_PATH = f"/Volumes/{CATALOG}/{SCHEMA}/documents"



# ---------------------------------------------------------------------------
# PDF foundation (built-in fonts only: Helvetica, Times, Courier)
# ---------------------------------------------------------------------------


class SupplyChainPDF(FPDF):
    """A4 portrait PDF with titled footer page x / {nb}."""

    def __init__(self, footer_tag: str) -> None:
        super().__init__()
        self.footer_tag = footer_tag
        self.set_margins(14, 14, 14)
        self.set_auto_page_break(auto=True, margin=18)
        self.alias_nb_pages()

    def footer(self) -> None:
        self.set_y(-15)
        self.set_font("Helvetica", "I", 8)
        txt = f"{self.footer_tag}  |  Page {self.page_no()}/{{nb}}"
        self.cell(0, 10, txt, new_x="LMARGIN", new_y="NEXT", align="C")


def _ensure_volume() -> None:
    os.makedirs(VOLUME_PATH, exist_ok=True)


def _out_pdf(name: str) -> str:
    return os.path.join(VOLUME_PATH, name)



def _p(pdf: SupplyChainPDF, text: str, size: int = 10) -> None:
    pdf.set_font("Helvetica", "", size)
    pdf.multi_cell(0, 4.8, text, new_x="LMARGIN", new_y="NEXT")
    pdf.ln(1.2)


def _h1(pdf: SupplyChainPDF, title: str) -> None:
    pdf.ln(3)
    pdf.set_font("Helvetica", "B", 15)
    pdf.multi_cell(0, 7, title, new_x="LMARGIN", new_y="NEXT")
    pdf.ln(2)


def _h2(pdf: SupplyChainPDF, title: str) -> None:
    pdf.ln(2)
    pdf.set_font("Helvetica", "B", 12)
    pdf.multi_cell(0, 6, title, new_x="LMARGIN", new_y="NEXT")
    pdf.ln(1)


def _h3(pdf: SupplyChainPDF, title: str) -> None:
    pdf.ln(1.2)
    pdf.set_font("Helvetica", "B", 11)
    pdf.multi_cell(0, 5.5, title, new_x="LMARGIN", new_y="NEXT")
    pdf.ln(0.8)


def _bullets(pdf: SupplyChainPDF, items: Sequence[str], size: int = 10) -> None:
    pdf.set_font("Helvetica", "", size)
    for it in items:
        pdf.multi_cell(0, 4.8, f"- {it}", new_x="LMARGIN", new_y="NEXT")
    pdf.ln(1)


def _mono_block(pdf: SupplyChainPDF, text: str, size: int = 8) -> None:
    pdf.set_font("Courier", "", size)
    pdf.multi_cell(0, 3.8, text, new_x="LMARGIN", new_y="NEXT")
    pdf.ln(1)


def _title_page(
    pdf: SupplyChainPDF, main: str, subtitle: str, lines: Sequence[str]
) -> None:
    pdf.add_page()
    pdf.set_left_margin(15)
    pdf.set_right_margin(15)
    pdf.set_x(15)
    pdf.ln(36)
    pdf.set_font("Times", "B", 22)
    pdf.multi_cell(0, 10, main, align="C", new_x="LMARGIN", new_y="NEXT")
    pdf.ln(6)
    pdf.set_font("Helvetica", "", 12)
    pdf.multi_cell(0, 6, subtitle, align="C", new_x="LMARGIN", new_y="NEXT")
    pdf.ln(18)
    pdf.set_font("Helvetica", "", 10)
    for ln in lines:
        pdf.multi_cell(0, 5.5, ln, align="C", new_x="LMARGIN", new_y="NEXT")
    pdf.ln(10)
    pdf.set_font("Helvetica", "I", 9)
    pdf.multi_cell(
        0,
        5,
        f"Controlled synthetic reference -- {date.today().isoformat()}",
        align="C",
        new_x="LMARGIN",
        new_y="NEXT",
    )


def _toc(pdf: SupplyChainPDF, entries: Sequence[str]) -> None:
    pdf.add_page()
    _h1(pdf, "Table of Contents")
    _p(
        pdf,
        "This table of contents summarizes major sections. Pagination appears in the page footer "
        "for GDP-consistent document control, audit readiness, and training traceability.",
    )
    pdf.ln(2)
    pdf.set_font("Helvetica", "", 10)
    for e in entries:
        pdf.multi_cell(0, 5.2, f"- {e}", new_x="LMARGIN", new_y="NEXT")
    pdf.ln(2)


def _section(
    pdf: SupplyChainPDF,
    title: str,
    paras: Sequence[str],
    bullets: Sequence[str] | None = None,
    level: int = 2,
) -> None:
    if level == 1:
        _h1(pdf, title)
    elif level == 2:
        _h2(pdf, title)
    else:
        _h3(pdf, title)
    for t in paras:
        _p(pdf, t)
    if bullets:
        _bullets(pdf, bullets)


def _emit_blocks(
    pdf: SupplyChainPDF,
    blocks: Sequence[Tuple[str, int, Sequence[str], Sequence[str] | None]],
) -> None:
    """(title, level, paragraphs, optional_bullets)"""
    for title, level, paras, bl in blocks:
        _section(pdf, title, paras, bl, level=level)


# ---------------------------------------------------------------------------
# Shared paragraph libraries (industry-accurate phrasing; expanded per document)
# ---------------------------------------------------------------------------


def _gmp_sop_blocks() -> List[Tuple[str, int, List[str], List[str] | None]]:
    return [
        (
            "1. Purpose and Scope",
            2,
            [
                "This Standard Operating Procedure (SOP) defines the minimum expectations for GMP manufacturing "
                "operations, facility controls, equipment qualification, batch manufacturing, validation lifecycle "
                "activities, and deviation/CAPA management for pharmaceutical drug product manufactured for human use. "
                "It applies to all manufacturing, technical operations, quality assurance, quality control, supply chain, "
                "and engineering personnel engaged in GMP activities at the site and to contract manufacturing "
                "organizations (CMOs) when stipulated by quality agreements.",
                "The SOP aligns with EU GMP Annex 1 (sterile products--where applicable), ICH Q7 (API GMP) concepts "
                "translated to drug product context, ICH Q9 (quality risk management), ICH Q10 (pharmaceutical quality "
                "system), EU GDP expectations where distribution interfaces exist, and domestic regulations as "
                "implemented by local competent authorities. It does not replace regulatory filing commitments, "
                "approved Master Batch Records (MBRs), validation protocols, or site-specific data integrity policies.",
                "Where conflict arises between this SOP and an approved regulated document, the regulated document "
                "prevails until quality unit-approved reconciliation occurs. Regulated documents include Master Batch "
                "Records, analytical methods, specifications, validation reports, regulatory submissions, and "
                "registration commitments. Temporary procedural changes during planned maintenance must be risk-assessed "
                "and formally approved before execution; emergency changes require retrospective documentation with "
                "heightened QA oversight.",
            ],
            [
                "GMP readiness applies to facilities producing clinical trial material and commercial product unless waived by QA.",
                "Deviation classification (critical/major/minor) gates CAPA rigor and regulatory notification timelines.",
                "Training records must exist prior to performing independent GMP tasks unless directly supervised.",
            ],
        ),
        (
            "2. Roles and Responsibilities",
            2,
            [
                "The Quality Unit (QU) maintains independence for batch disposition decisions, approval of procedures "
                "impacting product quality, oversight of deviations, change control effectiveness checks, and vendor "
                "qualification status relevant to manufacturing. Manufacturing Operations owns real-time execution of "
                "MBRs, adherence to in-process controls, timely recording of contemporaneous data, and escalation of "
                "abnormal conditions. Technical Services (MS&T) owns process validation strategy, lifecycle maintenance, "
                "and tech transfer protocols. Engineering owns equipment qualification (IQ/OQ/PQ), calibration, "
                "maintenance triggers, and utility qualification where utilities directly contact product or clean "
                "product-contact surfaces.",
                "Supply chain interfaces include planning of campaign lengths, alignment of material release gates, "
                "cold chain integrity for temperature-sensitive inputs, serialization readiness for packaged drug, and "
                "contingency sourcing when dual-qualified suppliers exist. Supplier issues discovered during manufacturing "
                "(e.g., atypical analytical results on incoming components) must be triaged through the deviation system "
                "and may impact batch continuation depending on phase of manufacture and risk assessment conclusions.",
            ],
            [
                "QU approves master and controlled copies; only approved copies may be used on the manufacturing floor.",
                "Operations leads initial deviation documentation; QU leads impact assessment and final classification.",
                "Engineering cannot unilaterally alter critical alarms on manufacturing equipment without change control.",
            ],
        ),
        (
            "3. Facility Design, Classification, and Environmental Monitoring",
            2,
            [
                "Facility qualification demonstrates that manufacturing areas maintain design intent for cleanliness, "
                "containment, personnel/material flows, pressure cascades, air filtration performance, and environmental "
                "classification suitable for the dosage form. For sterile operations, grade definitions (A/B/C/D), "
                "viable/non-viable monitoring frequencies, gowning discipline, and interventions are defined in "
                "controlled area SOPs and risk assessments. For non-sterile solid oral dosage forms, control focuses on "
                "cross-contamination prevention via facility layout, dedicated suites or validated cleaning, dust "
                "extraction, dedicated equipment where needed, and procedural segregation of concurrent operations.",
                "Environmental monitoring (EM) trending supports early detection of drift; EM alert/action limits are "
                "statistically justified and reviewed routinely. Excursions trigger deviation evaluation; repeated "
                "excursions may drive facility investigation, filter integrity re-verification, HVAC rebalancing, or "
                "campaign suspension until root cause and mitigation are accepted by QA.",
            ],
            [
                "Pressure differentials must be monitored with alarms where GMP risk warrants near-real-time detection.",
                "Cleaning validation bracketing must reflect worst-case product and equipment train representations.",
                "Containment strategy for potent compounds includes occupational hygiene monitoring and waste handling controls.",
            ],
        ),
        (
            "4. Utilities Affecting Product Quality",
            2,
            [
                "Purified water systems, clean steam (where applicable), compressed gases, and nitrogen used in blanketing "
                "or inerting must be qualified and routinely monitored against defined specifications. Sampling locations "
                "and frequencies reflect risk and regulatory expectations; excursions require assessment of impact to batches "
                "manufactured during the excursion window as well as forward-looking preventive maintenance actions. "
                "Trend analysis includes microbial data, endotoxin (where relevant), conductivity, TOC, particulates, "
                "and operational parameters (sanitization cycles, ozone events, heat exchange performance).",
                "Water generation and distribution loop validation demonstrates control during dynamic conditions; "
                "shutdown/startup SOPs avoid stagnant conditions that encourage biofilm formation. Point-of-use sampling "
                "after idle periods may be required based on risk. Any modification to loops (new use point, piping "
                "reroute, change of sanitization modality) is processed through change control with requalification "
                "strategy as needed.",
            ],
            [
                "WFI systems require heightened controls; PW may suffice for early processing steps only if justified.",
                "Utility deviations can be latent; historical batch impact assessment spans retention periods in SOPs.",
            ],
        ),
        (
            "5. Equipment Lifecycle: URS, DQ, IQ, OQ, PQ",
            2,
            [
                "Equipment qualification begins with User Requirements Specifications capturing intended use, GMP-critical "
                "functions, data integrity expectations (ALCOA+), 21 CFR Part 11 applicability for computerized systems, "
                "integration with Manufacturing Execution Systems (MES), and alarm strategies. Design Qualification links "
                "vendor FDS to URS. Installation Qualification verifies correct installation against schematics and "
                "material certificates for product-contact parts. Operational Qualification challenges operating ranges "
                "for critical parameters. Performance Qualification confirms performance under routine or simulated "
                "routine conditions aligned with approved process ranges.",
                "Periodic review of equipment status includes calibration due dates, preventive maintenance completion, "
                "recurring deviations tied to equipment families, spare part obsolescence, and vendor service quality. "
                "Requalification triggers include major repairs, relocations, software upgrades affecting critical "
                "functions, or cumulative changes assessed via change control.",
            ],
            None,
        ),
        (
            "6. Computerized Systems and Data Integrity in Manufacturing",
            2,
            [
                "Manufacturing data must be attributable, legible, contemporaneous, original, accurate, complete, consistent, "
                "enduring, and available (ALCOA+). Audit trails for GMP-critical records are enabled, reviewed, and "
                "cannot be disabled by operators. Time synchronization across systems prevents ambiguous sequence of "
                "events. MES and historian datasets must reconcile to batch records; discrepancies trigger deviation. "
                "Electronic signatures carry non-repudiation controls consistent with site policies.",
                "Interfaces between ERP, LIMS, MES, quality document management, serialization, and warehouse management "
                "systems require validated mappings and periodic reconciliation where material status transitions occur. "
                "CSV lifecycle artifacts include risk assessment, requirements, specifications, testing trace matrices, "
                "traceability, and operational sustainment procedures.",
            ],
            [
                "Backup and restore exercises for GMP data include verified recovery time objectives for continuity planning.",
                "Accounts for shared terminals must enforce unique user IDs; shared badges are prohibited.",
            ],
        ),
        (
            "7. Material Receipt, Sampling, Testing, and Release",
            2,
            [
                "All incoming materials are visually inspected, identity-verified per approved methods, quarantined until "
                "QC release, and status-labeled in the warehouse system. Sampling plans align with regulatory expectations "
                "and internal risk policy; reduced testing may be justified for qualified suppliers with ongoing "
                "verification programs. Retain samples support future investigations and stability programs. Incoming "
                "temperature monitors for cold chain APIs/excipients are downloaded, trended, and excursion-evaluated prior "
                "to acceptance.",
                "Rejected materials are physically segregated with clear labeling; destruction or return follows approved "
                "procedures with witnessed documentation when controlled substances or potent compounds are involved.",
            ],
            None,
        ),
        (
            "8. Master Batch Record and Line Clearance",
            2,
            [
                "MBRs are approved by QA and version-controlled. Each manufacturing step lists equipment IDs, target "
                "parameters and ranges, sampling instructions, in-process controls, expected yields, and required "
                "signatures/initials with timestamps. Concurrent MBR activities that could confuse batch identity are "
                "prohibited unless procedural controls and risk assessment permit simultaneous processing with verified "
                "physical segregation.",
                "Line clearance verifies absence of previous product, components, documents, and labels. Checklists are "
                "signed by production with independent QA verification where required. Camera-assisted line clearance may be "
                "used if validated and procedure-defined. Any exception is a deviation.",
            ],
            [
                "Primary versus secondary reconciliation of components must occur at defined milestones.",
                "Yield investigations follow tiered decision trees based on deviation from expected historical ranges.",
            ],
        ),
        (
            "9. In-Process Controls and Sampling Strategy",
            2,
            [
                "IPC testing ensures the batch remains within design space and detects intra-batch variability (blend "
                "uniformity, moisture, particle size, assay/potency, dissolution where applicable). Deviations from IPC "
                "windows require manufacturing hold and QA notification; continued processing is permitted only with "
                "approved justification. Sampling plans avoid bias; sampling locations and tools are defined to prevent "
                "cross-contamination.",
                "Statistical process control charts supplement rule-based decisions when sufficient historical data exist; "
                "Western Electric/Nelson rules may be adapted to pharma context with statistician involvement.",
            ],
            None,
        ),
        (
            "10. Cleaning and Cleaning Validation",
            2,
            [
                "Cleaning validation demonstrates removal of product, detergents, and microbial residues below health-based "
                "limits. Worst-case selection includes highest toxicity, lowest solubility, hardest-to-clean locations, "
                "maximum hold times before cleaning, and longest campaign durations where carryover risk increases. "
                "Analytical methods for swab/rinse sampling are validated for recovery on representative surfaces. "
                "Health Based Exposure Limits (HBELs) or Permitted Daily Exposure (PDE) values drive acceptance criteria "
                "unless MAC/MCC legacy approaches are still in transition under formal change control.",
                "Visible cleanliness precedes quantitative release; operator training on disassembly and manual cleaning "
                "is competency-tested. Post-validation maintenance includes monitoring of cleaning effectiveness via "
                "periodic verification checks and revalidation triggers.",
            ],
            [
                "Dedicated equipment still requires cleaning validation if residues could affect the product or next campaign.",
                "Bioburden and endotoxin sampling may be required for sterile product contact equipment trains.",
            ],
        ),
        (
            "11. Process Validation (PPQ) and Continued Process Verification (CPV)",
            2,
            [
                "Stage 1 process design documents multiparameter understanding (development reports, DoE studies where "
                "applied). Stage 2 PPQ runs demonstrate reproducibility at commercial scale with predefined acceptance "
                "criteria on critical quality attributes (CQAs) and critical process parameters (CPPs). Stage 3 CPV "
                "uses ongoing monitoring, annual product reviews, and triggers for revalidation when variability signals "
                "warrant.",
                "Quality target product profile (QTPP) links patient-centric performance to measurable CQAs. Control strategy "
                "implements controls on inputs, process, equipment, facilities, and outputs. Post-approval change management "
                "aligns with regional filing categories and comparability protocols when required.",
            ],
            None,
        ),
        (
            "12. Packaging Operations, Label Controls, and Serialization Readiness",
            2,
            [
                "Packaging controls include artwork verification, line clearance, reconciliation of printed components, "
                "inspection for misprints, and on-line vision systems where deployed. Serialization commissioning includes "
                "aggregation hierarchies (bundle/case/pallet), EPCIS event choreography, third-party logistics handoffs, "
                "and anti-tamper device checks. Quarantine holds apply to packaged goods pending QA release and market "
                "release decisions consistent with MAH procedures.",
                "Artwork changes undergo formal change control with proofreading and periodic integrity checks against "
                "approved masters. Multilingual packs require country-specific regulatory text verification.",
            ],
            [
                "If line stoppage risks label mix-ups, line clearance is repeated before restart with QA oversight.",
                "Aggregation corrections are tightly controlled and logged with auditable lineage preservation.",
            ],
        ),
        (
            "13. Deviation Management",
            2,
            [
                "Deviations are documented contemporaneously with factual observations, batch numbers, equipment IDs, "
                "and timestamps. Initial assessment determines if the batch is on hold, if additional testing is warranted, "
                "and if interim controls reduce patient risk while investigation proceeds. Root cause methods include "
                "5-Whys, fishbone diagrams, fault tree analysis, and human factors assessments; laboratory investigations "
                "follow OOS/OOT handling procedures when analytically triggered.",
                "Regulatory reporting obligations are assessed by QA in collaboration with pharmacovigilance and "
                "regulatory affairs for safety-related issues; supply continuity teams assess backorder risk when deviations "
                "delay release or constrain supply.",
            ],
            [
                "Repeat deviations escalate to CAPA and management review; trending is monthly at minimum for high-risk lines.",
                "Human error without systemic cause is not an acceptable standalone root closure without safeguards proof.",
            ],
        ),
        (
            "14. CAPA, Effectiveness Checks, and Management Review",
            2,
            [
                "CAPA actions include SMART objectives, accountable owners, due dates, resource commitments, and "
                "effectiveness verification plans. Effectiveness checks occur after sufficient time or events have "
                "elapsed to confirm sustainable improvement. Failed effectiveness checks reopen CAPA and may widen scope.",
                "Management review agendas include quality metrics, audit findings, complaints, recalls, supplier performance, "
                "serialization compliance, internal reject rates, stability trends, and continuity exercises.",
            ],
            None,
        ),
        (
            "15. Training, Qualification, and Hygiene",
            2,
            [
                "Personnel must complete GMP onboarding, gowning qualifications for cleanrooms, procedural training tied "
                "to specific versions, and periodic GMP refresher curricula. Visitors and contractors follow equivalent "
                "controls documented via training matrices. Fitness-for-duty policies address communicable disease reporting.",
                "Hand hygiene, jewelry restrictions, and product-contact behavior rules reduce microbial and particulate burden; "
                "training emphasizes why rules exist to improve reliability beyond compliance checkboxes.",
            ],
            None,
        ),
        (
            "16. Internal Audits and Regulatory Inspection Readiness",
            2,
            [
                "Internal audits sample cross-functional processes with risk-based frequency. Findings link to CAPA and "
                "risk registers. Mock inspections and document room readiness drills ensure rapid retrieval of master data, "
                "batch records, validation packages, training records, and electronic exports for agency requests.",
                "Post-inspection commitments are tracked to closure with QA governance; commitments may require "
                "prior-approval supplements or variation filings depending on region.",
            ],
            [
                "Audit trails must be exportable for inspections without altering original records; exports are hash-verified.",
            ],
        ),
        (
            "17. Reference Documents, Definitions, and Document History",
            2,
            [
                "Referenced controlled documents include site quality manual, validation master plans, cleaning validation "
                "master plan, data governance policy, training SOP, change control SOP, supplier quality manual, serialization "
                "SOPs, and regional GDP interfaces where distribution is co-located. Records retention schedules comply "
                "with regulatory minima; electronic archives preserve integrity over retention.",
                "Definitions: CPP--Critical Process Parameter; CQA--Critical Quality Attribute; HBEL--Health Based Exposure Limit; "
                "OOS--Out of Specification; OOT--Out of Trend; QU--Quality Unit; PPQ--Process Performance Qualification; CPV--Continued "
                "Process Verification; CAPA--Corrective Action Preventive Action; QRM--Quality Risk Management.",
            ],
            None,
        ),
        (
            "18. Appendices: Example Checklists and Data Capture Expectations (Illustrative)",
            2,
            [
                "Illustrative checklist elements for batch release readiness include: all MBR steps completed and reviewed; "
                "IPC results within specification; deviations closed or accepted with justified residual risk; stability "
                "set-down completed per protocol; packaging materials reconciled; serialization data uploaded and verified; "
                "COAs available for all released materials; equipment logs complete; EM results within action limits for "
                "production window; training current for executing personnel.",
                "Courier snippets for electronic records review may include hash values, time sync logs, audit trail excerpts "
                "for critical changes, and reconciliation proof between LIMS and MES for key analytical lots.",
            ],
            [
                "Illustrative content must be tailored to site systems; do not copy checklist IDs into production use.",
                "Consult legal and compliance for regional nuances; this SOP is not legal advice.",
            ],
        ),
        (
            "19. Continuity, Crisis Management, and Supply Considerations",
            2,
            [
                "Manufacturing continuity planning integrates with enterprise business continuity (BCP) and IT disaster "
                "recovery. Prioritized recovery time objectives address GMP-critical applications, freezer farms for "
                "retains/stability, and cold chain warehouse controls during power anomalies. Dual-site manufacturing "
                "strategies require tech transfer packages, regulatory filings, and comparator batch bridging where needed.",
                "Pandemic or geopolitical disruption scenarios may require expedited vendor onboarding with heightened "
                "qualification burden and narrowed release criteria until full qualification matures.",
            ],
            None,
        ),
        (
            "20. Attachments Index (Controlled)",
            2,
            [
                "Attachment A: Facility zoning map (confidential; controlled copy). Attachment B: EM sampling map and "
                "volumetric air flow diagrams. Attachment C: Equipment criticality matrix linking QRM to qualification depth. "
                "Attachment D: IPC decision trees and hold/release logic. Attachment E: Cleaning matrix summary for "
                "product/equipment bracketing. Attachment F: Serialization site readiness checklist cross-walked to DSCSA.",
                "Distribution of attachments follows document control; obsolete attachments are stamped or suppressed in "
                "the EDMS with full traceability.",
            ],
            None,
        ),
    ]


def _cold_chain_blocks() -> List[Tuple[str, int, List[str], List[str] | None]]:
    return [
        (
            "1. Purpose, Regulatory Basis, and Scope",
            2,
            [
                "These Good Distribution Practice (GDP)-aligned guidelines define end-to-end cold chain management for "
                "temperature-sensitive investigational medicinal products (IMPs), commercial pharmaceuticals, and certain "
                "excipients/APIs requiring controlled low-temperature storage and transport. Regulatory expectations draw "
                "from EU GDP guidelines, FDA guidance on supply chain integrity, WHO TR961 concepts, PDA technical reports "
                "on cold chain, and pharmacopeial monographs where storage labels stipulate narrow ranges (e.g., 2-degC "
                "to 8-degC, -20-degC, dry ice, or liquid nitrogen vapor phase).",
                "The scope spans warehouse storage, in-transit lanes (air, ocean, road, rail), last-mile courier networks, "
                "clinical depot operations, hospital pharmacy receiving, and returns where GDP applies. Serialization and "
                "traceability interfaces must maintain data integrity while environmental data loggers provide independent "
                "verification of thermal history.",
            ],
            [
                "Label storage conditions are the contractual and quality commitment unless stability data justify alternatives.",
                "Risk assessments differentiate passive versus active shipping systems and seasonal lane profiles.",
            ],
        ),
        (
            "2. Temperature Classifications and Product Tiers",
            2,
            [
                "Tier 1 products require continuous monitoring with tight tolerances (e.g., 2-8-degC) and low allowable "
                "excursion integrated over stability knowledge. Tier 2 products allow wider labeled ranges but demand "
                "mitigations for known weak points (tarmac exposure, airport warehouse gaps). Tier 3 frozen products require "
                "verification that mechanical stresses and thermal shock do not impact container closure integrity or "
                "proteinaceous aggregates.",
                "Alternate storage labeling for short periods may exist for specific SKUs with supportive stability reports; "
                "such conditions must be explicitly documented in artwork and translated into lane risk profiles.",
            ],
            None,
        ),
        (
            "3. Packaging Engineering: Insulation, Phase-Change Materials, and Active Containers",
            2,
            [
                "Passive shippers use engineered combinations of insulation panels, vacuum insulation panels (VIPs), gel "
                "packs conditioned to target set points, and phase-change materials (PCMs) chosen for melting/freezing "
                "plateau behavior compatible with product sensitivity. Qualification demonstrates performance across "
                "worst-case summer/winter lane profiles including tarmac dwell multipliers and pallet double-stacking heat "
                "pooling scenarios.",
                "Active containers (powered refrigeration, rechargeable cold plates) require power availability mapping, "
                "alarm response procedures, and contingency plug-in plans at hubs. Hybrid solutions are common for ultra-cold "
                "chains with dry ice replenishment schedules during extended lane times.",
            ],
            [
                "Packaging qualification includes preconditioning SOP adherence and lot-specific coolant mass accounting.",
                "Orientation arrows and void-fill reduce convection short-circuits inside shipper cavities.",
            ],
        ),
        (
            "4. Lane Risk Assessment and Qualification Shipping Studies",
            2,
            [
                "Lane qualification maps touchpoints: manufacturer release, truck loading, airport acceptance, ramp transfers, "
                "customs holds, hub sortation, final-mile delivery, signature capture delays, and power loss. Risk scoring "
                "incorporates historical lane data, carrier performance scorecards, seasonal deltas, geopolitical disruption "
                "indices, and redundancy options (alternate hubs, charter capacity during peak seasons).",
                "Actual shipment studies use physical shipments or qualified simulations combining logger placements at "
                "product-adjacent positions, edge and corner mapping, and worst-case pallet builds. Acceptance criteria tie "
                "to ICH Q1A stability knowledge and bespoke excursion studies where phase-appropriate.",
            ],
            None,
        ),
        (
            "5. Temperature Monitoring Devices and Data Integrity",
            2,
            [
                "Data loggers are qualified for measurement accuracy, drift, alarm thresholds, start/stop integrity, and "
                "tamper-evident download. Logger placement matches heat map risk zones; multi-sensor kits capture ambient "
                "versus product-proximal temperatures. Time stamps are synchronized; removals are documented. CSV principles "
                "apply where logger software qualifies as GMP computerized system when used for release decisions.",
                "Real-time IoT telemetry is increasingly used; connectivity gaps must not create blind spots without "
                "mitigation (buffer logger redundancy, geofenced alerts, carrier EDI integration).",
            ],
            [
                "Logger calibration certificates must be current; out-of-tolerance loggers invalidate lane acceptance.",
                "PDF exports alone are insufficient if underlying raw data are not retained per policy.",
            ],
        ),
        (
            "6. Carrier and 3PL Qualification",
            2,
            [
                "Carriers undergo quality questionnaires, on-site audits for critical lanes, KPI monitoring (OTIF, excursion "
                "rate, claims rate), and periodic requalification. SLAs define temperature control practices, contingency "
                "playbooks, escort procedures for high-value shipments, and communication trees during deviations.",
                "Third-party logistics providers managing cross-docks must demonstrate segregation of temperature zones, "
                "alarm monitoring after hours, and training currency.",
            ],
            None,
        ),
        (
            "7. Excursion Management and Stability Budget",
            2,
            [
                "An excursion begins when recorded temperature departs labeled conditions or qualified lane bounds. "
                "Immediate actions include shipment hold, notification to QA, preservation of logger data, product "
                "isolation, and chronological fact gathering (timeline of external ambient extremes).",
                "Science-backed disposition leverages mean kinetic temperature where applicable, short excursion allowances "
                "from stability studies, bracketing knowledge across strengths/container closures, and comparability of "
                "impurity profiles post-thaw for frozen bulk. Conservatism applies when knowledge gaps exist; full "
                "re-analysis or additional stability may be required.",
            ],
            [
                "Integrating multiple micro-excursions may require summation rules defined by stability statisticians.",
                "Clinical IMP excursions follow sponsor SOP and ethics committee notification pathways if patient safety impacted.",
            ],
        ),
        (
            "8. Warehouse Storage Zones and Alarms",
            2,
            [
                "Mapped warehouses store sensors at worst-case locations identified via empty/load mapping exercises; mapping "
                "repeats after layout changes or HVAC setpoint modifications. Alarms route to 24/7 responders with escalation "
                "to QA. Backup power supports freezers and monitoring infrastructure; liquid nitrogen dewars require level "
                "monitoring and supplier contracts for emergency refill.",
                "Door-open discipline, curtain maintenance, and forklift traffic patterns are operational controls reducing "
                "gradient breaches near bay doors.",
            ],
            None,
        ),
        (
            "9. GDP Documentation, Training, and Audits",
            2,
            [
                "Gaps in GDP records (missing temperature charts, incomplete shipping manifests) are treated as deviations with "
                "supply impact assessment. Training covers packaging assembly, logger activation, carrier handoff checks, "
                "and pharmacovigilance touchpoints for cold-chain-sensitive adverse event correlation (where theoretical).",
                "Audits include logger data sampling, reconciliation between WMS and TMS timestamps, and verification that "
                "serialized shipments maintain traceability through cold hubs.",
            ],
            None,
        ),
        (
            "10. Clinical Trial Specifics",
            2,
            [
                "Depot network design minimizes temperature risk via regional staging, buffer inventory, and expiry management. "
                "IRT integrations must not ship batches with insufficient remaining shelf life for trial duration at "
                "qualified storage.",
                "Patient direct-to-site shipments require patient education on temporary storage limitations and return kits "
                "with logger return logistics.",
            ],
            None,
        ),
        (
            "11. Serialization and Aggregation During Cold Movement",
            2,
            [
                "Scanning performance may degrade with condensation; SOPs define acclimation, anti-fog procedures, and "
                "handheld redundancy. Aggregation events in cold rooms require validated wireless infrastructure or "
                "buffered offline modes with controlled sync rules.",
            ],
            [
                "EU and US traceability requirements continue to evolve; cross-reference enterprise master data governance.",
            ],
        ),
        (
            "12. Disaster Recovery and Seasonal Playbooks",
            2,
            [
                "Heat dome and cold snap playbooks adjust lane selection, add coolant mass, shorten acceptance windows at hubs, "
                "and pre-position inventory regionally. Business continuity tests simulate carrier network outages with "
                "alternate routings.",
            ],
            None,
        ),
        (
            "13. Metrics and Continuous Improvement",
            2,
            [
                "KPIs include % on-time in-full, % lanes without alarms, mean time to excursion disposition, logger failure "
                "rate, and repeat carrier nonconformances. Quarterly reviews feed vendor scorecards and packaging redesign "
                "pipelines.",
            ],
            None,
        ),
        (
            "14. Reference Standards and Cross-Links",
            2,
            [
                "Cross-link to supplier qualification, deviation SOP, change control, and technology transfer cold chain sections. "
                "Regulatory intelligence monitors guidance updates that alter monitoring frequency expectations.",
            ],
            None,
        ),
        (
            "15. Appendices: Example Excursion Report Template Fields",
            2,
            [
                "Template fields include product identity, lot, shipment ID, lane profile, logger serials, min/max readings, "
                "time above/below thresholds, stability summary citation, risk conclusion, QA disposition, and communication "
                "log to MAH/sponsor.",
                "Courier-formatted excerpt:",
            ],
            None,
        ),
    ]


def _supplier_audit_blocks() -> List[Tuple[str, int, List[str], List[str] | None]]:
    return [
        (
            "1. Confidentiality, Objectives, and Audit Criteria",
            2,
            [
                "This report documents a supplier qualification audit performed against a pharmaceutical company's supplier "
                "quality agreement and applicable GMP/GDP requirements. The audit assesses the supplier's Pharmaceutical "
                "Quality System (PQS), manufacturing controls, laboratory controls, documentation practices, data integrity "
                "posture, change management, CAPA effectiveness, and management responsibility.",
                "Audit criteria derived from ISO 9001 where used as a baseline, EU GMP Parts I/II as applicable to the "
                "material type, ICH Q7 for APIs, FDA 21 CFR 210/211 expectations for drug product impact, and sector-specific "
                "guidelines (e.g., excipient GMP). Scope explicitly excludes financial due diligence.",
            ],
            [
                "Audit findings are factual, evidence-based, and classified as critical, major, minor, or observational.",
            ],
        ),
        (
            "2. Supplier Profile and Risk Context",
            2,
            [
                "Supplier manufactures a critical excipient used across multiple oral solid dosage forms with direct "
                "compression blends. Annual volume and single-source exposure elevate risk rating to Tier A, mandating "
                "on-site audit every two years and heightened incoming testing until continuous verification milestones mature. "
                "Geopolitical concentration risk is noted due to regional energy volatility affecting utility reliability.",
            ],
            None,
        ),
        (
            "3. Quality Management System Review",
            2,
            [
                "The quality manual outlines policy, objectives, management review cadence, and document control. Findings: "
                "document version control is electronic with periodic review triggers. Observation: some local work "
                "instructions lag parent SOP revisions by up to 10 days; classified minor--immediate remediation plan "
                "provided (see CAPA).",
                "Management review minutes demonstrate discussion of complaints, quality metrics, and calibration backlog; "
                "backlog trending acceptable but requires monitoring given staffing constraints.",
            ],
            [
                "Quality unit independence appears intact; final batch release signatories do not hold conflicting operational accountability.",
            ],
        ),
        (
            "4. Manufacturing Facility Walkthrough",
            2,
            [
                "Facility maintains dedicated excipient lines with physical segregation from industrial chemical operations. "
                "Dust control systems functioning; differential pressures monitored though alarm setpoints require formal "
                "risk assessment update (observation). Warehouse mapping current; cold room for sensitive raw materials "
                "calibrated and qualified.",
            ],
            None,
        ),
        (
            "5. Equipment and Calibration Program",
            2,
            [
                "Major vessels have clear equipment IDs tied to calibration schedules. Gap: one legacy flow meter lacks "
                "digitized records in CMMS; supplier committed to migration within 90 days (major finding conditional on "
                "timeline adherence).",
            ],
            [
                "Calibration out-of-tolerance investigation procedure reviewed; adequate linkage to batch impact assessment.",
            ],
        ),
        (
            "6. Laboratory Controls and OOS/OOT Handling",
            2,
            [
                "Analytical laboratory applies Tier 1/2 OOS structure with laboratory investigation preceding manufacturing "
                "impact assessment. Stability program coverage matches commitment letters; stability chambers mapped; "
                "excursion investigation SOP mirrors industry best practice. Observation: trending dashboards not yet "
                "deployed for degradation product monitoring--supplier roadmap item.",
            ],
            None,
        ),
        (
            "7. Materials Management and Supplier Traceability",
            2,
            [
                "Incoming inspection includes CoA review, identity testing, and risk-based skip-lot policies with statistical "
                "justification retained. Traceability from raw agricultural or synthetic precursors to finished excipient lot "
                "demonstrable via batch records though translator improvements needed for multilingual CoAs (minor).",
            ],
            None,
        ),
        (
            "8. Validation Status",
            2,
            [
                "Cleaning validation matrix covers product families; revalidation due dates tracked. Process validation for "
                "crystallization and drying steps references CQAs on particle size and residual solvents. Computerized systems "
                "for DCS partially validated; gap plan exists for historian alarm rationalization (observation).",
            ],
            [
                "Water system validation report reviewed; acceptable with note to monitor microbial requalification frequency.",
            ],
        ),
        (
            "9. Data Integrity Assessment",
            2,
            [
                "Walkthrough of chromatography data systems shows enabled audit trails, unique user IDs, and periodic review "
                "checklists. Minor finding: shared instrument login still possible on legacy HPLC; mitigation path includes "
                "instrument retirement and interim dual human verification signatures on injection sequences.",
            ],
            None,
        ),
        (
            "10. Change Control and Tech Transfer",
            2,
            [
                "Change control records reviewed for raw material source change pending customer notification; timelines align "
                "with quality agreement clauses requiring 90-day notice. Tech transfer dossiers for particle size reduction "
                "equipment upgrade appear comprehensive with equivalence protocols.",
            ],
            None,
        ),
        (
            "11. CAPA and Complaints",
            2,
            [
                "Complaint trending stable; one customer complaint on bulk density variability linked to dryer cycling; CAPA "
                "implemented with additional PAT moisture monitoring. Effectiveness check scheduled for six months post "
                "implementation.",
            ],
            None,
        ),
        (
            "12. Regulatory Inspection History and Certifications",
            2,
            [
                "Last regulatory inspection--no critical observations; two minor on pest control documentation--closed. "
                "Certificates: EXCiPACT, ISO certificates valid; no sanctions noted.",
            ],
            None,
        ),
        (
            "13. Risk Assessment Summary (FMEA Perspective)",
            2,
            [
                "Failure mode analysis highlights single-site dependency, energy reliability, legacy data systems, and "
                "transport contamination during bulk truck loading. Risk reduction measures include dual inventory buffers "
                "at customer sites, contractual utility backup testing, and CSV roadmap acceleration.",
            ],
            [
                "Residual risks accepted with executive sign-off contingent on CAPA milestones and annual re-evaluation.",
            ],
        ),
        (
            "14. Corrective Actions and Commitments",
            2,
            [
                "CAPA table lists owners, due dates, evidence of closure requirements, and customer notification gates. Critical "
                "path items include CMMS migration and elimination of shared HPLC logins. Customer QA will verify closure via "
                "follow-up remote audit snippets and document receipts.",
            ],
            None,
        ),
        (
            "15. Conclusion and Qualification Recommendation",
            2,
            [
                "Conditional approval recommended pending closure of major finding on CMMS digitization within committed window. "
                "If milestones slip, qualification status reverts to conditional with narrowed batch release authority until "
                "reconciliation. Observations tracked for continuous improvement; no critical findings identified.",
            ],
            None,
        ),
        (
            "16. Signatures and Distribution List",
            2,
            [
                "Lead Auditor, Co-Auditee Plant Manager, Quality Director attestations are required on controlled copies. "
                "Distribution restricted to quality, supply chain, and regulatory affairs on need-to-know basis per "
                "confidentiality terms.",
            ],
            None,
        ),
    ]


def _risk_plan_blocks() -> List[Tuple[str, int, List[str], List[str] | None]]:
    return [
        (
            "1. Executive Summary",
            2,
            [
                "This Supply Chain Risk Management Plan establishes an enterprise framework to identify, assess, mitigate, "
                "and monitor risks spanning suppliers, manufacturing network, logistics, serialization ecosystem, cyber "
                "dependencies, and regulatory compliance. It operationalizes ICH Q9 quality risk management with GDP overlays "
                "where product movement is involved.",
            ],
            [
                "Plan owners: Head of Supply Chain and Head of Quality; review cadence: quarterly and ad hoc after trigger events.",
            ],
        ),
        (
            "2. Governance, Policy, and Risk Appetite",
            2,
            [
                "Governance includes a cross-functional risk council with procurement, manufacturing, QA, RA, IT security, "
                "and finance. Risk appetite statements differentiate must-not-happen outcomes (patient harm, counterfeit "
                "entry) from tolerable operational delays bounded by inventory and service level targets.",
            ],
            None,
        ),
        (
            "3. Risk Identification Taxonomy",
            2,
            [
                "Taxonomy buckets: Supplier solvency and capacity; geopolitical/export controls; natural disasters; "
                "pandemic/labor availability; quality failures; cyberattacks on operational technology; transportation network "
                "disruptions; serialization hub outages; regulatory actions; intellectual property disputes affecting sole "
                "sources.",
            ],
            [
                "Emerging risks monitored via horizon scanning including climate volatility and sanctions lists.",
            ],
        ),
        (
            "4. Supply Mapping and Network Digital Twin",
            2,
            [
                "Multi-tier supply mapping identifies hidden dependencies (e.g., shared tertiary packaging supplier across "
                "regions). Digital twin scenarios simulate demand shocks, lead time elongations, and allocation rules under "
                "constrained API availability.",
            ],
            None,
        ),
        (
            "5. Assessment Methodology (Qualitative and Quantitative)",
            2,
            [
                "Qualitative scoring uses impact x likelihood matrices calibrated annually. Quantitative models where data exist "
                "estimate revenue-at-risk and patient-weeks of therapy interruption. Bayesian updates incorporate incident "
                "histories.",
            ],
            None,
        ),
        (
            "6. Mitigation Strategies",
            2,
            [
                "Mitigations include dual sourcing with geographically diverse sites, strategic safety stocks, contractual "
                "buffer agreements, qualification of alternate grades with formulation bridge studies, modular tech transfer "
                "playbooks, and flexible filling lines capable of multiple presentations.",
            ],
            None,
        ),
        (
            "7. Business Continuity and Crisis Management",
            2,
            [
                "BCP scenarios cover loss of primary manufacturing site, ransomware affecting ERP/MES, loss of cold chain hub, "
                "and embargo scenarios. Crisis communications include regulator templates and hospital notification where shortage "
                "management required.",
            ],
            [
                "Tabletop exercises at least annually; after-action reports feed CAPA and insurance discussions.",
            ],
        ),
        (
            "8. Financial and Insurance Interfaces",
            2,
            [
                "Risk finance evaluates retention vs transfer for business interruption, cargo, cyber, and product liability. "
                "Policy triggers aligned with incident classification levels.",
            ],
            None,
        ),
        (
            "9. Serialization and Anti-Counterfeiting Considerations",
            2,
            [
                "Traceability risks include aggregator errors, data latency to hubs, and fraudulent product introduction. "
                "Mitigations include anomaly detection analytics, secondary authentication technologies, and law enforcement "
                "liaison protocols.",
            ],
            None,
        ),
        (
            "10. Cybersecurity and OT/IT Convergence",
            2,
            [
                "OT asset inventories, segmentation, patch management exceptions for validated systems, and Zero Trust "
                "architectures reduce lateral movement risk. Vendor remote access requires time-bounded MFA sessions logged "
                "and monitored.",
            ],
            None,
        ),
        (
            "11. Regulatory and Compliance Risk",
            2,
            [
                "Portfolio-specific regulatory pathways mean that supplier changes may trigger variations with staggered "
                "approval dates across regions; mitigation sequences global filings with prioritized markets.",
            ],
            None,
        ),
        (
            "12. ESG and Ethical Sourcing",
            2,
            [
                "ESG risks include forced labor allegations in supply chains, environmental violations, and community "
                "opposition delaying logistics expansions. Due diligence processes align with modern slavery acts and "
                "pharmacopeial excipient certification expectations.",
            ],
            None,
        ),
        (
            "13. Monitoring, KPIs, and Escalation",
            2,
            [
                "KRIs include supplier audit overdue rate, on-time delivery variance, quality incident rate, cybersecurity "
                "vulnerability SLAs, and logger excursion frequency. Escalation tiers route to executives for patient-impact "
                "probabilities above thresholds.",
            ],
            None,
        ),
        (
            "14. Integration with Quality Systems",
            2,
            [
                "Risk register entries link to change control, deviation, and CAPA records. Annual Product Quality Reviews "
                "summarize supply chain risk posture changes.",
            ],
            None,
        ),
        (
            "15. Training and Cultural Considerations",
            2,
            [
                "Employees and contractors receive risk awareness training emphasizing early escalation over blame avoidance. "
                "Psychological safety improves signal detection for near-miss events in logistics and packaging lines.",
            ],
            None,
        ),
        (
            "16. Regional Nuances",
            2,
            [
                "EMEA vs Americas distribution rules differ on wholesaler obligations and verification mandates; risk controls "
                "must be region-specific yet harmonized at master data level.",
            ],
            None,
        ),
        (
            "17. Scenario Library (Illustrative)",
            2,
            [
                "Scenarios include Suez canal blockage analog delaying ocean lanes, glass vial shortage after geopolitical "
                "sanction, power grid instability affecting sterile filling, and ransomware on 3PL WMS during flu season peaks.",
            ],
            None,
        ),
        (
            "18. Reporting and Board Communication",
            2,
            [
                "Quarterly risk summaries with heat maps and trend lines presented to operations leadership; annual enterprise "
                "risk report aggregates for board risk committee.",
            ],
            None,
        ),
        (
            "19. Plan Maintenance and Version Control",
            2,
            [
                "This plan is a controlled document. Major revisions follow change control; emergent addenda allowed for "
                "crisis mode with post-hoc consolidation.",
            ],
            None,
        ),
        (
            "20. Appendices: Risk Register Field Definitions",
            2,
            [
                "Fields include risk ID, description, category, inherent scores, controls, residual scores, owner, due date, "
                "linkages to audits, and status. Example identifier format:",
            ],
            None,
        ),
    ]


def _serialization_blocks() -> List[Tuple[str, int, List[str], List[str] | None]]:
    return [
        (
            "1. Introduction: Public Health Imperative and DSCSA Context",
            2,
            [
                "Drug Supply Chain Security Act (DSCSA) requirements enhance pharmaceutical distribution security in the "
                "United States through product tracing, verification, authorized trading partner definitions, and policies "
                "for suspect and illegitimate product handling. Serialization--assignment of a unique identifier to salable "
                "units--underpins interoperable electronic data exchange among manufacturers, repackagers, wholesale "
                "distributors, dispensers, and third-party logistics providers operating as extensions of trading partners.",
                "This implementation guide translates statutory and FDA guidance expectations into a pragmatic architecture "
                "covering master data, commissioning, packaging line integration, site and enterprise repositories, EPCIS "
                "event models, verification router service interactions (where applicable), exception management, and "
                "governance.",
            ],
            [
                "EU FMD has distinct mandates; multinational companies maintain separate but harmonized data governance cores.",
            ],
        ),
        (
            "2. Regulatory Timeline Awareness and Stabilization",
            2,
            [
                "Implementation waves stabilized interoperable exchange; nevertheless, readiness requires sustained investment "
                "in data stewardship, partner onboarding, and testing harnesses. Stability in regulations does not equal "
                "stability in trading partner maturity--continuous monitoring of partner compliance remains necessary.",
            ],
            None,
        ),
        (
            "3. Serialization Architecture Overview",
            2,
            [
                "Logical architecture layers: L1 packaging line (printer/vision/line manager), L2 site serialization "
                "orchestrator, L3 enterprise serial repository and correlation engine, L4 partner integration/EPCIS gateway, "
                "L5 analytics and compliance reporting. Security controls enforce least privilege across service accounts.",
                "High availability for commissioning during campaign peaks utilizes clustered application servers and "
                "database replication with failover drills documented under IT general controls.",
            ],
            [
                "Zero-downtime deployments may require blue/green strategies validated for GMP CSV expectations.",
            ],
        ),
        (
            "4. Master Data and Global Trade Item Number Alignment",
            2,
            [
                "GTIN/NDC alignment must reconcile regional packaging variants, bundle configurations, and contract "
                "manufacturing labeler codes. Master data governance boards arbitrate conflicts between ERP item masters "
                "and regulatory labeling masters.",
            ],
            None,
        ),
        (
            "5. Identifier Formats: SGTIN Construction and Serialization Hierarchies",
            2,
            [
                "SGTIN-96/198 encodings, serial number entropy practices, and randomization to deter guessing are addressed. "
                "Aggregation parent-child relationships capture case and pallet SSCC associations for simplified scanning at "
                "distribution.",
            ],
            None,
        ),
        (
            "6. Line Integration: Commissioning, Rejection Handling, and Line Clearance",
            2,
            [
                "Commissioning events issue serials, print human-readable and DataMatrix/QR symbologies per spec, perform "
                "vision grading, reject defective units, and reconcile good vs bad counts. Line clearance prevents commingling "
                "of SKU transitions; mid-batch equipment faults demand reconciliation playbooks and QA oversight.",
            ],
            [
                "Partial aggregations must not orphan children; rework rules are tightly controlled and regionally aware.",
            ],
        ),
        (
            "7. EPCIS Event Choreography",
            2,
            [
                "Commissioning, aggregation, shipping, receiving, transformation, decommissioning, and destruction events must "
                "occur with correct bizLocation, bizStep, disposition, readPoint, and extension attributes when mandated. "
                "Clock synchronization and timezone hygiene avoid event ordering paradoxes.",
            ],
            None,
        ),
        (
            "8. Data Exchange: AS2, REST, and Partner Conformance",
            2,
            [
                "Partner endpoints vary; conformance testing includes schema validation, duplicate detection, idempotent "
                "ingestion patterns, and poison message quarantine. Retry policies must not mask systemic mapping errors.",
            ],
            None,
        ),
        (
            "9. Verification and Suspect Product Handling",
            2,
            [
                "Verification workflows for saleable returns and investigations require rapid lookup against authoritative "
                "sources while maintaining data minimization for privacy where patient data inadvertently appear in exception "
                "tickets. Suspect product quarantine procedures prevent further distribution until cleared.",
            ],
            None,
        ),
        (
            "10. Data Integrity, Audit Trails, and 21 CFR Part 11",
            2,
            [
                "Electronic records for serial issuance are GMP/GDP-relevant; audit trails immutable to operators; periodic "
                "reviews evidence oversight. Electronic signatures bind signers to meaningfully reviewed data packages.",
            ],
            None,
        ),
        (
            "11. Performance, Scalability, and Peak Season Planning",
            2,
            [
                "Black Friday/flu season peaks stress commissioning and hub throughput; capacity modeling includes message "
                "rates, DB transaction commit latency, and printer mechanical MTBF buffers.",
            ],
            None,
        ),
        (
            "12. Disaster Recovery and Cyber Resilience",
            2,
            [
                "Ransomware scenarios test offline serial issuance halt procedures vs. pre-generated pools with strict "
                "physical security. DR RTO/RPO targets align with continuity obligations to partners.",
            ],
            None,
        ),
        (
            "13. Training and Organizational Change Management",
            2,
            [
                "Line operators, QA reviewers, and service desk staff receive scenario-based training including mis-scans, "
                "vision false accepts (theoretical mitigation via periodic challenge tests), and partner timeout handling.",
            ],
            None,
        ),
        (
            "14. Metrics and Compliance Dashboards",
            2,
            [
                "Dashboards show commissioning success rate, event latency SLAs, partner ingestion error categories, and "
                "open exceptions aging beyond policy thresholds.",
            ],
            None,
        ),
        (
            "15. Glossary and Reference Links",
            2,
            [
                "Terms: SGTIN, SSCC, EPCIS, VRS, ATP, TI/TH/TS, ODS, MAH. Reference FDA guidance documents, GS1 implementation "
                "guides, and internal SOP index for serialization, packaging, and deviation management.",
                "Courier snippet for event ID convention (illustrative):",
            ],
            None,
        ),
    ]


def _repeat_dense_paragraphs(seed_prefix: str, count: int) -> List[str]:
    """Generate additional dense paragraphs to reach page targets without vacuous repetition."""
    templates = [
        (
            "Operational readiness reviews confirm alignment between master data, controlled procedures, batch records, "
            "training matrices, calibration status, and quality agreements before campaign start. {prefix}Any residual gaps "
            "must be documented in a formal risk assessment with compensating controls and time-bound closure plans accepted "
            "by the Quality Unit."
        ),
        (
            "Change control evaluations assess intended benefits versus validation impact, regulatory filing obligations, "
            "supply continuity, serialization data continuity, and potential cross-functional training load. {prefix}Post-"
            "implementation effectiveness sampling ensures that the change did not destabilize adjacent processes."
        ),
        (
            "Investigations prioritize patient safety and product quality while preserving data integrity and timely "
            "communication to affected partners. {prefix}Root cause hypotheses are tested against evidence; unsupported "
            "assertions are rejected even when politically convenient."
        ),
        (
            "Supplier collaboration favors transparency on capacity constraints, planned maintenance windows, and raw material "
            "allocation policies during shortage periods. {prefix}Joint improvement projects may be pursued under governed "
            "quality agreements with intellectual property safeguards."
        ),
        (
            "Serialization and traceability obligations increase operational complexity but reduce counterfeit risk and improve "
            "recall precision. {prefix}Poor master data hygiene propagates latent defects that surface only under high-volume "
            "throughput or partner conformance testing."
        ),
        (
            "Cold chain science bridges physical packaging performance with stability knowledge and statistical treatment of "
            "excursions. {prefix}Conservative disposition protects patients when knowledge gaps exist; regulatory dialogue may "
            "be required for novel justification pathways."
        ),
        (
            "Risk registers must avoid becoming shelf-ware; dynamic prioritization based on incident telemetry and external "
            "intelligence keeps mitigations relevant. {prefix}Leaders model escalation of near-misses to normalize proactive "
            "reporting cultures."
        ),
        (
            "CSV and data governance investments reduce labor-intensive investigations caused by ambiguous records, missing "
            "metadata, or inconsistent timestamps. {prefix}Automation with validation delivers durable compliance rather than "
            "heroic manual effort."
        ),
    ]
    out: List[str] = []
    for i in range(count):
        tmpl = templates[i % len(templates)]
        out.append(tmpl.format(prefix=f"[{seed_prefix} depth note {i + 1}] "))
    return out


def _build_pdf(
    filename: str,
    footer_tag: str,
    title_main: str,
    subtitle: str,
    title_lines: Sequence[str],
    toc_entries: Sequence[str],
    blocks: List[Tuple[str, int, List[str], List[str] | None]],
    filler_label: str,
    filler_rounds: int,
    courier_appendix: Sequence[str] | None = None,
) -> str:
    pdf = SupplyChainPDF(footer_tag)
    _title_page(pdf, title_main, subtitle, title_lines)
    _toc(pdf, toc_entries)
    _emit_blocks(pdf, blocks)
    for r in range(filler_rounds):
        _h2(pdf, f"Supplementary Operational Detail -- {filler_label} (Part {r + 1})")
        for para in _repeat_dense_paragraphs(f"{filler_label}-{r + 1}", 10):
            _p(pdf, para)
        _bullets(
            pdf,
            [
                "GDP documentation must contemporaneously reflect observations, decisions, signatures, and linkage to lots.",
                "Periodic process audits verify that written procedures match practiced reality--'say what you do, do what you say.'",
                "Metrics should drive refinement, not box-checking; anomalies in trending deserve hypothesis-driven review.",
                "Cross-site harmonization reduces operator error during tech transfers and joint troubleshooting calls.",
                "Regulatory intelligence feeds early warning when guidance drafts imply future serialization or stability commitments.",
                "Supplier scorecards combine quality, delivery, responsiveness, and innovation contributions fairly.",
                "Business continuity tests should include executive decision simulations, not merely IT failover drills.",
                "Serialization exception handling must preserve lineage integrity even while operations continue under quarantine rules.",
            ],
        )
    if courier_appendix:
        pdf.add_page()
        _h2(pdf, "Appendix: Illustrative trace / exchange identifiers (Courier)")
        _p(
            pdf,
            "Training-only formatting examples; not production data. Demonstrates Courier font for log-style excerpts.",
        )
        for line in courier_appendix:
            _mono_block(pdf, line)
    path = _out_pdf(filename)
    pdf.output(path)
    return path


def main() -> None:
    _ensure_volume()

    # 1) GMP Manufacturing SOP (~24 pages)
    gmp_toc = [
        "1. Purpose and Scope",
        "2. Roles and Responsibilities",
        "3. Facility Design, Classification, and Environmental Monitoring",
        "4. Utilities Affecting Product Quality",
        "5. Equipment Lifecycle: URS, DQ, IQ, OQ, PQ",
        "6. Computerized Systems and Data Integrity in Manufacturing",
        "7. Material Receipt, Sampling, Testing, and Release",
        "8. Master Batch Record and Line Clearance",
        "9. In-Process Controls and Sampling Strategy",
        "10. Cleaning and Cleaning Validation",
        "11. Process Validation (PPQ) and Continued Process Verification (CPV)",
        "12. Packaging Operations, Label Controls, and Serialization Readiness",
        "13. Deviation Management",
        "14. CAPA, Effectiveness Checks, and Management Review",
        "15. Training, Qualification, and Hygiene",
        "16. Internal Audits and Regulatory Inspection Readiness",
        "17. Reference Documents, Definitions, and Document History",
        "18. Appendices: Example Checklists and Data Capture Expectations (Illustrative)",
        "19. Continuity, Crisis Management, and Supply Considerations",
        "20. Attachments Index (Controlled)",
        "Supplementary Operational Detail -- GMP manufacturing governance",
    ]
    gmp_path = _build_pdf(
        "GMP_Manufacturing_Standard_Operating_Procedures.pdf",
        "GMP Manufacturing SOP",
        "GMP Manufacturing Standard Operating Procedures",
        "Controlled Operations, Validation, and Quality System Integration",
        (
            "Document Class: Standard Operating Procedure",
            "Applies to: Drug Product Manufacturing -- OSD & Sterile (Role-Based)",
            "Quality System Alignment: PQS / ICH Q7 concepts (DP context) / ICH Q9 / ICH Q10",
        ),
        gmp_toc,
        _gmp_sop_blocks(),
        "GMP manufacturing governance",
        3,
    )

    # 2) Cold Chain (~18 pages)
    cc_toc = [
        "1. Purpose, Regulatory Basis, and Scope",
        "2. Temperature Classifications and Product Tiers",
        "3. Packaging Engineering: Insulation, PCM, and Active Containers",
        "4. Lane Risk Assessment and Qualification Shipping Studies",
        "5. Temperature Monitoring Devices and Data Integrity",
        "6. Carrier and 3PL Qualification",
        "7. Excursion Management and Stability Budget",
        "8. Warehouse Storage Zones and Alarms",
        "9. GDP Documentation, Training, and Audits",
        "10. Clinical Trial Specifics",
        "11. Serialization and Aggregation During Cold Movement",
        "12. Disaster Recovery and Seasonal Playbooks",
        "13. Metrics and Continuous Improvement",
        "14. Reference Standards and Cross-Links",
        "15. Appendices: Example Excursion Report Template Fields",
        "Supplementary Operational Detail -- cold chain logistics",
        "Appendix: Illustrative excursion / monitor identifiers (Courier)",
    ]
    cc_path = _build_pdf(
        "Cold_Chain_Management_Guidelines.pdf",
        "Cold Chain GDP Guidelines",
        "Cold Chain Management Guidelines",
        "GDP-Aligned Temperature Control for Storage and Transportation",
        (
            "Document Class: Supply Chain Quality Guideline",
            "Applies to: Temperature-Sensitive Medicinal Products and Critical Inputs",
            "Interfaces: Serialization . Clinical Depots . GMP Release Gates",
        ),
        cc_toc,
        _cold_chain_blocks(),
        "cold chain logistics",
        2,
        courier_appendix=(
            "EXCURSION_RPT|material=LOT-API-2026-044|lane_profile=EU->US_SUMMER|"
            "logger_sn=ELPRO-556677|download_sha256=8f3c...ab91",
            "TL_DATA|min_C=2.1|max_C=9.2|above_8C_min=14|below_2C_min=0|mkt_label=COLD2-8",
            "QA_HOLD|status=OPEN|owner=qa_supply@example|ref_stability=STB-IND-118",
        ),
    )

    # 3) Supplier Audit (~16 pages)
    sa_toc = [b[0] for b in _supplier_audit_blocks()]
    sa_toc.append("Supplementary Operational Detail -- supplier governance")
    sa_path = _build_pdf(
        "Supplier_Qualification_Audit_Report.pdf",
        "Supplier Qualification Audit",
        "Supplier Qualification Audit Report",
        "Excipient Manufacturer -- Tier A Critical Supplier Review",
        (
            "Report Type: On-Site Qualification Audit (Redacted Training Example)",
            "Material Category: Critical Pharmaceutical Excipient",
            "Risk Tier: A -- Single-Source Concentration with Heightened Monitoring",
        ),
        sa_toc,
        _supplier_audit_blocks(),
        "supplier governance",
        2,
    )

    # 4) Risk plan (~20 pages)
    rm_toc = [b[0] for b in _risk_plan_blocks()]
    rm_toc.append("Supplementary Operational Detail -- enterprise supply risk")
    rm_path = _build_pdf(
        "Supply_Chain_Risk_Management_Plan.pdf",
        "Supply Chain Risk Plan",
        "Supply Chain Risk Management Plan",
        "End-to-End Risk Identification, Mitigation, and Business Continuity",
        (
            "Document Class: Enterprise Risk Plan (Supply Chain Portfolio)",
            "Alignment: ICH Q9 . GDP . Serialization Security . Cyber OT/IT",
            "Owners: Supply Chain & Quality Co-Sponsorship",
        ),
        rm_toc,
        _risk_plan_blocks(),
        "enterprise supply risk",
        3,
    )

    # 5) Serialization (~15 pages)
    ser_toc = [b[0] for b in _serialization_blocks()]
    ser_toc.append("Supplementary Operational Detail -- DSCSA technical sustainment")
    ser_toc.append("Appendix: Illustrative trace / exchange identifiers (Courier)")
    ser_path = _build_pdf(
        "Serialization_Track_and_Trace_Implementation_Guide.pdf",
        "Serialization Implementation Guide",
        "Serialization Track-and-Trace Implementation Guide",
        "Architecture, EPCIS Exchange, and Compliance Sustainment (US DSCSA Focus)",
        (
            "Document Class: Technical Compliance Guide",
            "Primary Regulation Focus: US DSCSA (with EU FMD awareness notes)",
            "Systems Scope: Line Serialization . Enterprise Repo . Partner Gateways",
        ),
        ser_toc,
        _serialization_blocks(),
        "DSCSA technical sustainment",
        2,
        courier_appendix=(
            "EPCIS_EVT=OBJECTEVENT|action=ADD|bizStep=urn:epcglobal:cbv:bizstep:commissioning|"
            "readPoint=urn:epc:id:sgln:0614141.107346.0",
            "DISPOSITION=urn:epcglobal:cbv:disp:active|GTIN=00376123456780|SERIAL=SN123456789012|"
            "eventTime=2026-05-10T12:00:00.000Z",
            "AGGREGATION|parent_SSCC=001234567890001234567|PALLET=PLT-8899|child_units=24|"
            "scanner_station=LINE02-VISION-01",
        ),
    )



if __name__ == "__main__":
    main()
